Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market was valued at US$ 902.3 million in 2023 and is antici...
Bumetanide is used to treat swelling caused by heart failure or liver or kidney disease.
The global Bumetanide Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bumetanide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CA...
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
The global Tildrakizumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR o...
LIBTAYO(Cemiplimab-rwlc)® is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation.
The global Cemiplimab-rwlc market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessin...
Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dutasteride is estimated to increase from $ million in 2023 to reach $...
Anakinra (brand name Kineret) is a biopharmaceutical drug used to treat rheumatoid arthritis. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan
The global Anakinra market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2...
Albuterol Sulfate Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
The global Albuterol Sulfate Inhalation Aerosol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
N...
Albuterol sulfate (albuterol sulfate inhalation solution) is a bronchodilator used to treat or prevent bronchospasm in people with reversible obstructive airway disease.
The global Albuterol Sulfate Inhalation Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Al...
Tracleer (bosentan) is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the vessels of the lungs.
The global Tracleer (bosentan) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American...
Tobramycin eye drops are prescribed to treat bacterial eye infections.
The global Tobramycin Eye Drop market was valued at US$ 320 million in 2023 and is anticipated to reach US$ 488.8 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
North American market for Tobramycin Eye Drop is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals